Gen9 Garners $1,550,001 Series B Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d7a59f1d-0c41-43e5-a2b2-225dcd047919&Preview=1 -
Date
9/9/2011 -
Company Name
Gen9 -
Mailing Address
500 Technology Sq. Cambridge, MA 01239 -
Company Description
The company is developing synthetic biology technologies. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$1,550,001 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds purposes were not disclosed. Amount reflects value of Series B Preferred Stock to be sold & Series B Preferred Stock underlying Warrants and Promissory Notes. Amount Sold reflects value of Preferred Stock sold. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
